• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型生物相关溶出介质作为基于多糖的结肠靶向给药系统的预后工具。

Novel biorelevant dissolution medium as a prognostic tool for polysaccharide-based colon-targeted drug delivery system.

作者信息

Yadav Ankit Kumar, Sadora Manik, Singh Sachin Kumar, Gulati Monica, Maharshi Peddi, Sharma Abhinav, Kumar Bimlesh, Rathee Harish, Ghai Deepak, Malik Adil Hussain, Garg Varun, Gowthamrajan K

机构信息

Department of Pharmaceutics, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.

Department of Pharmaceutics, J.S.S. College of Pharmacy, Ooty, Tamil Nadu, India.

出版信息

J Adv Pharm Technol Res. 2017 Oct-Dec;8(4):150-155. doi: 10.4103/japtr.JAPTR_70_17.

DOI:10.4103/japtr.JAPTR_70_17
PMID:29184847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5680623/
Abstract

To overcome the limitations of the conventionally used methods for evaluation of orally administered colon-targeted delivery systems, a novel dissolution method using probiotics has been recently reported. In the present study, universal suitability of this medium composed of five different probiotics is established. Different delivery systems - mini tablets, liquisolid compacts, and microspheres coated with different polysaccharides - were prepared and subjected to sequential dissolution testing in medium with and without microbiota. The results obtained from fluid thioglycollate medium (FTM)-based probiotic medium for all the polysaccharide-based formulations showed statistically similar dissolution profile to that in the rat and goat cecal content media. Hence, it can be concluded that the developed FTM-based probiotic medium, once established, may eliminate the need for further animal sacrifice in the dissolution testing of polysaccharide-based colon-targeted delivery system.

摘要

为克服传统用于评估口服结肠靶向给药系统的方法的局限性,最近报道了一种使用益生菌的新型溶出方法。在本研究中,确定了这种由五种不同益生菌组成的培养基的普遍适用性。制备了不同的给药系统——迷你片、液固型制剂和涂覆不同多糖的微球,并在有和没有微生物群的培养基中进行连续溶出测试。从基于巯基乙酸盐流体培养基(FTM)的益生菌培养基中获得的所有基于多糖的制剂的结果显示,其溶出曲线与大鼠和山羊盲肠内容物培养基中的溶出曲线在统计学上相似。因此,可以得出结论,所开发的基于FTM的益生菌培养基一旦确定,可能无需在基于多糖的结肠靶向给药系统的溶出测试中进一步进行动物处死。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac6/5680623/ef147ff76381/JAPTR-8-150-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac6/5680623/793d498983a7/JAPTR-8-150-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac6/5680623/6923beabf3f4/JAPTR-8-150-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac6/5680623/ef147ff76381/JAPTR-8-150-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac6/5680623/793d498983a7/JAPTR-8-150-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac6/5680623/6923beabf3f4/JAPTR-8-150-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac6/5680623/ef147ff76381/JAPTR-8-150-g008.jpg

相似文献

1
Novel biorelevant dissolution medium as a prognostic tool for polysaccharide-based colon-targeted drug delivery system.新型生物相关溶出介质作为基于多糖的结肠靶向给药系统的预后工具。
J Adv Pharm Technol Res. 2017 Oct-Dec;8(4):150-155. doi: 10.4103/japtr.JAPTR_70_17.
2
A novel dissolution method for evaluation of polysaccharide based colon specific delivery systems: A suitable alternative to animal sacrifice.一种用于评估基于多糖的结肠特异性给药系统的新型溶出方法:动物牺牲的合适替代方法。
Eur J Pharm Sci. 2015 Jun 20;73:72-80. doi: 10.1016/j.ejps.2015.03.012. Epub 2015 Mar 28.
3
A novel dissolution media for testing drug release from a nanostructured polysaccharide-based colon specific drug delivery system: an approach to alternative colon media.一种用于测试基于纳米结构多糖的结肠特异性药物递送系统药物释放的新型溶出介质:替代结肠介质的方法。
Int J Nanomedicine. 2016 Mar 17;11:1089-95. doi: 10.2147/IJN.S97177. eCollection 2016.
4
Development of polysaccharide-based colon targeted drug delivery systems for the treatment of amoebiasis.用于治疗阿米巴病的多糖基结肠靶向给药系统的研发。
Drug Dev Ind Pharm. 2007 Mar;33(3):255-64. doi: 10.1080/03639040600897127.
5
An investigation of physicochemical properties of piroxicam liquisolid compacts.吡罗昔康液固复合制剂的物理化学性质研究。
Pharm Dev Technol. 2007;12(3):337-43. doi: 10.1080/10837450701247574.
6
In vitro release evaluation of hydrocortisone liquisolid tablets.氢化可的松液固混合片的体外释放度评价
J Pharm Sci. 1998 Jul;87(7):867-72. doi: 10.1021/js970346g.
7
Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties.液固技术作为增强难溶性药物及评估其理化性质的一种工具。
Acta Pharm. 2007 Mar;57(1):99-109. doi: 10.2478/v10007-007-0008-6.
8
The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.载体的类型和浓度对难溶性药物(吲哚美辛)从液固分散体中的溶出速率的影响。
J Pharm Pharm Sci. 2005 Jan 12;8(1):18-25.
9
Effect of co-administration of probiotics with polysaccharide based colon targeted delivery systems to optimize site specific drug release.益生菌与多糖基结肠靶向递送系统联合给药对优化特定部位药物释放的影响。
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):164-72. doi: 10.1016/j.ejpb.2015.09.012. Epub 2015 Sep 28.
10
Enhancement of dissolution rate of piroxicam using liquisolid compacts.使用液固复合制剂提高吡罗昔康的溶出速率。
Farmaco. 2005 Apr;60(4):361-5. doi: 10.1016/j.farmac.2004.09.005.

引用本文的文献

1
Effect of Source and Degree of Esterification of High Methoxyl Pectin on Oral Colon-Targeted Multiparticulated Delivery of Otilonium Bromide.高甲氧基果胶的来源和酯化程度对溴化奥替溴铵口服结肠靶向多颗粒递送的影响。
ACS Omega. 2025 Aug 4;10(32):36481-36495. doi: 10.1021/acsomega.5c04979. eCollection 2025 Aug 19.
2
Methods to Study Colon Release: State of the Art and An Outlook on New Strategies for Better Biorelevant Release Media.研究结肠释放的方法:最新技术水平及对更好生物相关释放介质新策略的展望
Pharmaceutics. 2019 Feb 22;11(2):95. doi: 10.3390/pharmaceutics11020095.

本文引用的文献

1
Role of synbiotics in polysaccharide assisted colon targeted microspheres of mesalamine for the treatment of ulcerative colitis.合生元在美沙拉嗪多糖辅助结肠靶向微球治疗溃疡性结肠炎中的作用。
Int J Biol Macromol. 2017 Feb;95:438-450. doi: 10.1016/j.ijbiomac.2016.11.066. Epub 2016 Nov 19.
2
A novel dissolution media for testing drug release from a nanostructured polysaccharide-based colon specific drug delivery system: an approach to alternative colon media.一种用于测试基于纳米结构多糖的结肠特异性药物递送系统药物释放的新型溶出介质:替代结肠介质的方法。
Int J Nanomedicine. 2016 Mar 17;11:1089-95. doi: 10.2147/IJN.S97177. eCollection 2016.
3
Effect of co-administration of probiotics with polysaccharide based colon targeted delivery systems to optimize site specific drug release.
益生菌与多糖基结肠靶向递送系统联合给药对优化特定部位药物释放的影响。
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):164-72. doi: 10.1016/j.ejpb.2015.09.012. Epub 2015 Sep 28.
4
A novel dissolution method for evaluation of polysaccharide based colon specific delivery systems: A suitable alternative to animal sacrifice.一种用于评估基于多糖的结肠特异性给药系统的新型溶出方法:动物牺牲的合适替代方法。
Eur J Pharm Sci. 2015 Jun 20;73:72-80. doi: 10.1016/j.ejps.2015.03.012. Epub 2015 Mar 28.
5
Facts, fallacies and future of dissolution testing of polysaccharide based colon-specific drug delivery.基于多糖的结肠靶向药物递送的溶出度测试的事实、谬论和未来。
J Control Release. 2014 Mar 28;178:55-62. doi: 10.1016/j.jconrel.2014.01.010. Epub 2014 Jan 15.
6
Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.采用液质联用技术研究制剂参数对格列吡嗪溶出速率的影响。
Drug Dev Ind Pharm. 2012 Aug;38(8):961-70. doi: 10.3109/03639045.2011.634810. Epub 2012 Jan 18.
7
Development of pH- and enzyme-controlled, colon-targeted, pulsed delivery system of a poorly water-soluble drug: preparation and in vitro evaluation.开发一种 pH 和酶控制的、结肠靶向的、脉冲释放的难溶性药物递送系统:制备和体外评价。
Drug Dev Ind Pharm. 2010 Jan;36(1):81-92. doi: 10.3109/03639040903092335.
8
Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.肠道pH值、转运时间和进食状态对pH响应型回肠-结肠释放系统体内性能的相互作用。
Pharm Res. 2008 Aug;25(8):1828-35. doi: 10.1007/s11095-008-9580-9. Epub 2008 May 9.
9
Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil.膜胶囊中的不对称膜:实现头孢羟氨苄延迟和渗透流动的一种手段。
Eur J Pharm Biopharm. 2008 Jun;69(2):658-66. doi: 10.1016/j.ejpb.2007.12.011. Epub 2007 Dec 23.
10
Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery.用于结肠给药的肠溶果胶酸钙微球的研制。
Eur J Pharm Biopharm. 2008 Jun;69(2):508-18. doi: 10.1016/j.ejpb.2007.12.004. Epub 2007 Dec 15.